| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 09/30/2004 | CA2519372A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators |
| 09/30/2004 | CA2519220A1 Amino cyclobutylamide modulators of chemokine receptor activity |
| 09/30/2004 | CA2519026A1 Therapeutic and/or preventive agent for chronic skin disease |
| 09/30/2004 | CA2518973A1 Methods for isolating crystalline form i of 5-azacytidine |
| 09/30/2004 | CA2517446A1 6-sulfonamide quinoline and chromene derivative as androgen receptor antagonists |
| 09/29/2004 | EP1461334A2 Pyrazole derived kinase inhibitors |
| 09/29/2004 | EP1461330A1 3h-naphtho 2,1-b]-pyrane derivatives and the use of the same |
| 09/29/2004 | EP1461321A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 09/29/2004 | EP1461320A2 Enantioselective transformation of alfa,beta-unsaturated ketones using chiral organic catalysts |
| 09/29/2004 | EP1389202B1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 09/29/2004 | EP1189881B1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/29/2004 | EP1181278B1 Cyclic amine derivatives and their uses |
| 09/29/2004 | EP1165557B1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS |
| 09/29/2004 | EP1051397A4 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound |
| 09/29/2004 | EP1012140B1 New amidino derivatives and their use as thrombin inhibitors |
| 09/29/2004 | EP0901487B9 2,3,6 trisubstituted-4(3h)-quinazolinones |
| 09/29/2004 | CN1533382A 哌嗪衍生物 Piperazine derivatives |
| 09/29/2004 | CN1532635A Organic light sensitive body with epoxy charge transfer compound |
| 09/29/2004 | CN1168722C Diresorinyl-alkoxy-and-aryloxy-s-triazines |
| 09/29/2004 | CN1168720C Aryl alkanoylpyridazines compounds |
| 09/29/2004 | CN1168719C 6-phenylpyridyl-2-amine derivatives and pharmaceutical composition and use |
| 09/29/2004 | CN1168704C Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide |
| 09/28/2004 | US6797820 Succinate compounds, compositions and methods of use and preparation |
| 09/28/2004 | US6797714 Hypoglycemic agents; antidiabetic agents; side effect reduction |
| 09/28/2004 | US6797713 1,4 substituted piperazines, 1,4 substituted piperidines, and 1-substituted,4-alkylidenyl piperidine compounds; dual acting molecules having both leukotriene inhibition properties |
| 09/28/2004 | US6797712 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain |
| 09/28/2004 | US6797710 Cardiovascular disorders; serine protease inhibitor; administering by mouth; bioavailability |
| 09/28/2004 | US6797708 Enzyme inhibitors such as 4-(2-(1-benzhydryl-2-(2-((benzyl-sulfonyl)amino)ethyl)-5-chloro-1h-indol-3 -yl)ethoxy) benzoic acid, used as analgesics or antiinflammatory agents |
| 09/23/2004 | WO2004081005A1 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
| 09/23/2004 | WO2004081004A1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| 09/23/2004 | WO2004081003A1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholeterolemia |
| 09/23/2004 | WO2004080999A1 Pyrazole compounds useful in the treatment of inflammation |
| 09/23/2004 | WO2004080990A1 C-glycoside derivatives and salts thereof |
| 09/23/2004 | WO2004080982A1 Pyrazine compounds as transforming growth factor (tgf) inhibitors |
| 09/23/2004 | WO2004080981A1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands |
| 09/23/2004 | WO2004080980A1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 09/23/2004 | WO2004080977A1 4-substituted-5-cyano-1h-pyrimidin-6-(thi)ones as gsk-3 inhibitors |
| 09/23/2004 | WO2004080976A1 Phthalazinone derivatives |
| 09/23/2004 | WO2004080973A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors |
| 09/23/2004 | WO2004080972A1 Pirazole modulators of atp-binding cassette transporters |
| 09/23/2004 | WO2004080969A1 Quinolinone / benzoxazinone derivatives and uses thereof |
| 09/23/2004 | WO2004080968A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 09/23/2004 | WO2004080480A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 09/23/2004 | WO2004080463A1 Heterocyclic kinase inhibitors: methods of use and synthesis |
| 09/23/2004 | WO2004080411A2 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
| 09/23/2004 | WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same |
| 09/23/2004 | WO2004043884A3 Novel acylating reagents |
| 09/23/2004 | WO2004041258A3 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 09/23/2004 | WO2004005472A3 Inhibitors of ftsz and uses thereof |
| 09/23/2004 | WO2003072552A8 Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide |
| 09/23/2004 | WO2003011219A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 09/23/2004 | US20040186296 Process to produce derivatives from uk-2a derivatives |
| 09/23/2004 | US20040186295 G protein-coupled receptors activators such as 2-[2-(3-chlorophenyl)-2H-tetrazol-5-yl]pyridine, used as analgesics, anxiolytic, antidepressants, and for prophylaxis of psychological disorders |
| 09/23/2004 | US20040186287 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides |
| 09/23/2004 | US20040186284 Methods for isolating crystalline form I of 5-azacytidine |
| 09/23/2004 | US20040186170 Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient |
| 09/23/2004 | US20040186168 Such as spiroadamantane on one side and 4-substituted spiro-cyclohexyl on other side; structurally simple, nontoxic, easy synthesis, potent parasiticides |
| 09/23/2004 | US20040186159 used to treat glaucomatous optic neuropathy and/or lower and control intraocular pressure (IOP) associated with normal-tension glaucoma, ocular hypertension, and/or glaucoma in warm blooded animals, including man |
| 09/23/2004 | US20040186156 useful for solid tumors and leukemia; auto-immune diseases such as psoriasis, alopecia and multiple sclerosis; cardiovascular diseases such as stenoses, arterioscleroses and restenoses; infectious diseases caused by unicellular parasites; nephrological diseases, neurodegenerative diseases |
| 09/23/2004 | US20040186153 Pharmaceutical use of N-carbamoylazole derivatives |
| 09/23/2004 | US20040186151 E.g., 2-[3-(4'-Methoxyphenyl)-propionylamino]-2-(4'-n-butoxy-3'-carboxyphenyl)-2-ethyl[4-(4'-nitrophenyl)]imidazole; inhibitors of protein tyrosine phosphatases; antidiabetic, -carcinogenic, -inflammation agents; antiallergens; infections; modulation of growth hormones/factors; Alzeimer's; obesity |
| 09/23/2004 | US20040186148 E.g., 1-(pyrid-2-yl-so2-),2-((4-(isopropylphenyl)-so2-),5-(isopropoxy)benzene; antiinflammatory agents; immunomodulatory activity rheumatoid arthritis, asthma, allergy, psoriasis, Crohn's disease, systemic lupus erythematosus, multiple sclerosis, diabetes, cancer, glaucoma, osteoporosis, renal ischemia |
| 09/23/2004 | US20040186140 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
| 09/23/2004 | US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
| 09/23/2004 | US20040186125 E.g , 3-cyclohexyl-2-furan-3-yl-1Hindole-5-carboxylic acid; hepatitis C viricides that target RNA dependent RNA polymerases (Ns5B) in mammals, an enzyme essential to viral replication; used in conjunction with an mmunomodulatory agent, such as beta -, delta - gamma -, and omega -interferon |
| 09/23/2004 | US20040186119 glycogen synthase kinase (GSK-3) inhibitors; for treatment of diabetes and alzheimer's disease |
| 09/23/2004 | US20040186118 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 09/23/2004 | US20040186116 such as 2-(7-acetylamino-1-furano-2-ylmethyl-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-succinic acid; for treatment of autoimmune diseases, proliferative diseases, angiogenic disorders, and/or cancers; catheters, prosthetics |
| 09/23/2004 | US20040186113 Heterocyclic amines for the treatment of conditions associated with gsk-3 |
| 09/23/2004 | US20040186099 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 09/23/2004 | US20040186098 Method for preventing and treating hearing loss using sensorineurotrophic compounds |
| 09/23/2004 | US20040186097 such as N-phenyl-3-[[4-(phenylmethyl)-1-piperidinyl]methyl]-1-piperidinecarboxamide for prevention of asthma and allergies |
| 09/23/2004 | US20040186092 Tertiary carbocyclic amides such as 1-(3-Piperazin-1-yl-benzyl)-3,4-dihydro-1H-quinolin-2-one, used as serotonin receptor antagonists for prophylaxis of nervous system disorders and gastrointestinal disorders |
| 09/23/2004 | US20040186090 New amidino derivatives and their use as thrombin inhibitors |
| 09/23/2004 | US20040185553 Apparatus comprised of highly absorbent particles immobilized to inert matrix for removal of substances from blood products; dialysis |
| 09/23/2004 | US20040185544 Batch devices for the reduction of compounds from biological compositions containing cells and methods of use |
| 09/23/2004 | US20040185255 Indeno-fused photochromic naphthopyrans, naphthols and photochromic articles |
| 09/23/2004 | DE10311065A1 New 1-(cyclic amino-alkyl)-pyrimidin-2(1H)-one derivatives, are selective dopamine D3 receptor ligands useful for treating CNS disorders, especially schizophrenia or depression |
| 09/23/2004 | CA2518403A1 Quinolinone/benzoxazinone derivatives and uses thereof |
| 09/23/2004 | CA2518398A1 Heterocyclic kinase inhibitors: methods of use and synthesis |
| 09/23/2004 | CA2518194A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 09/23/2004 | CA2517885A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors |
| 09/23/2004 | CA2517720A1 Pyrazine compounds as transforming growth factor (tgf) inhibitors |
| 09/22/2004 | EP1460073A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/22/2004 | EP1460072A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/22/2004 | EP1460070A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/22/2004 | EP1460069A1 Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators |
| 09/22/2004 | EP1460062A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
| 09/22/2004 | EP1458714A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 09/22/2004 | EP1458712A2 Novel compounds |
| 09/22/2004 | EP1458703A1 Isochroman compounds for treatment of cns disorders |
| 09/22/2004 | EP1458700A2 Substituted 2-phenyl benzofurans as estrogenic agents |
| 09/22/2004 | EP1458691A2 Benzodiazepine derivatives, preparation thereof and use thereof |
| 09/22/2004 | EP1458687A2 Pyrimidine compounds |
| 09/22/2004 | EP1458686A1 Benzocyclodecane derivatives with antitumor activity |
| 09/22/2004 | EP1458685A2 Substituted phenyl derivatives |
| 09/22/2004 | EP1458684A2 Therapeutic heterocycles |
| 09/22/2004 | EP1458679A2 Pyrrolidine derivatives as prostaglandin modulators |
| 09/22/2004 | EP1458394A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3 |